CuresNow works with GCPN to bring its pro-cloning crusade to TV

LOS ANGELES: The debate over human cloning is coming to the small screen, with a new series of ads featuring Harry and Louise, the down-home couple that helped the insurance industry scuttle Clinton's healthcare plans in 1994.

LOS ANGELES: The debate over human cloning is coming to the small screen, with a new series of ads featuring Harry and Louise, the down-home couple that helped the insurance industry scuttle Clinton's healthcare plans in 1994.

CuresNow, a Hollywood-based group in favor of cloning for disease research, hired Goddard Claussen Porter Novelli (GCPN) to raise awareness of current legislation that would ban all types of cloning - whether for reproduction or to create stem cells for research.

Two entertainment industry power couples that both have daughters with juvenile diabetes, a disease that may be a candidate for a genetic cure, founded the organization. Also working with DC lobbyists Mayer Brown, CuresNow's founders contacted GCPN, the original creators of the Harry and Louise campaign, for a similar effort.

"People relate to (Harry and Louise) as people just like themselves," said Ben Goddard, partner at GCPN. "Louise has an ability to take complex-sounding terms and phrases and say them in such a way that sounds very normal, very natural, and makes complete sense."

Media interest in the couple's resurrection is already high, with articles in The New York Times, the LA Times, The Weekly Standard, and the San Francisco Examiner.

However, there have been reports that the Health Insurance Association of America (HIAA), which funded the original Harry and Louise campaign, plans to sue CuresNow and GCPN.

While Goddard admitted getting "several calls

from HIAA on the matter, he said Harry and Louise are under no contractual obligation with the group.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.